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The role of pertussis toxin (PT)-sensitive and -insen- 
sitive  guanine nucleotide-binding proteins (G proteins) 
in  the stimulation of Ca2+ mobilization by thrombin 
was investigated in cultured rat aortic smooth  muscle 
cells. Characterization using immunoblotting with spe- 
cific antisera indicated the presence in isolated mem- 
branes of the Gaiz, Gai3, Ga., G@sa, and GB36 protein 
subunits as well as a lower molecular weight species of 
unknown identity. To assess the importance of G pro- 
teins in the coupling of thrombin receptors to Ca2+ 
mobilization, we investigated the effect of PT on Ca" 
responses using fluorescence spectroscopy and  the Ca2+ 
indicator dye Fura-2.  Pretreatment of cells for 2 h 
with PT (1 Fg/ml), which produced 91.3% ADP-ribo- 
sylation of PT-sensitive G proteins, did not affect the 
magnitude of thrombin-induced release of Caz+ from 
internal stores, suggesting that  the residual 8.7% of 
PT-sensitive G proteins, or PT-insensitive mecha- 
nisms, was responsible for Ca2+ release. However, after 
an  18-h  pretreatment  with PT, which produced ADP- 
ribosylation of the total complement of PT-sensitive G 
proteins, the thrombin-induced peak Ca2+ response 
was inhibited by approximately 72%, suggesting that 
the major fraction of the Ca2+ response was mediated 
by a slowly ribosylating component. The delayed effect 
of the toxin was not caused by down-regulation of the 
@-subunit of G proteins because quantitative immuno- 
blots showed that levels of the @-subunit remained 
constant throughout the period of PT pretreatment. It 
was also not caused by a reduction in  the size of the 
thrombin-releasable Ca2+ pool  because Ca2+ release  in- 
duced  by agents that release Ca" directly from inter- 
nal stores, 2,6-di-tert-butylhydroquinone or thapsi- 
gargin,  was not affected. In addition, the delayed effect 
of PT could  not be explained in  terms of differences in 
thrombin-induced [SH]inositol trisphosphate (IPS) for- 
mation because the level of inhibition of IP, formation 
after a 2-h PT  treatment was  similar to that present 
after an 18-h  pretreatment. 
The  results  indicate that a slowly ribosylating PT- 
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sensitive species is the major G protein pathway that 
couples thrombin-receptor activation to Ca2+ mobili- 
zation. This G protein  appears to be involved not in  the 
mechanisms that generate IPS but rather possibly in 
coupling at  the level of the  intracellular Ca" store. 
a-Thrombin elicits a wide variety of important responses 
in vascular cells. In endothelial cells, it increases the  intra- 
cellular Ca2+ concentration [Ca2+]il (1, 2), increases the 
expression of mRNA for platelet-derived growth factor BB 
(3), and  stimulates the release of endothelial-derived relaxing 
factor (4). In the absence of endothelium, a-thrombin is a 
potent vasoconstrictor agent (5) and  in some instances may 
also be mitogenic (6). It stimulates many growth-related sig- 
nals in vascular smooth muscle including Na+/H+ exchange 
( 6 4 ,  mRNA for the protooncogene c-fos (81, and protein 
synthesis (6). It also activates phospholipase C with the 
generation of diacylglycerol and inositol 1,4,5-trisphosphate 
(IPS) (6). The last substance is closely associated with an 
early elevation in [Ca2+Ii (9). Many of the above mentioned 
responses to a-thrombin appear dependent on this early ele- 
vation in [Ca"],. 
A rise in [Ca2+Ii is the primary trigger for many cellular 
processes in vascular smooth muscle. An elevation in Ca2+ 
triggers cell contraction via activation of myosin light chain 
kinase (10). Ca2+ has also been demonstrated to stimulate 
directly the expression of c-fos mRNA in vascular smooth 
muscle (11, 12). In other cell types Ca2+ has been demon- 
strated to modulate gene expression leading to increases in 
the levels of c-fos  mRNA  (13, 14), c-my mRNA  (15, 16),  and 
repression of  c-jura mRNA (14). A rise in Ca2+ has also been 
observed to precede the onset of anaphase in Swiss 3T3 cells, 
suggesting that transient elevations in Ca2+ are important 
during particular stages of the cell  cycle (17). 
There is increasing evidence to suggest that a variety of 
guanine nucleotide-binding proteins (G proteins)  are involved 
in signal transduction (18). In smooth muscle, G proteins 
have been suggested to be involved in  the coupling of receptors 
to phospholipase C (19), modulation of the Ca2+ sensitivity of 
The abbreviations used are: [Ca*+],, intracellular Caz+ concentra- 
tion; IPS, inositol 1,4,5-trisphosphate, G protein, guanine nucleotide- 
binding protein; Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesul- 
fonic acid; EGTA, [ethylenebis(oxyethylenenitrilo)]tetraacetic acid; 
PT, pertussis toxin; tBuBHQ, 2,5-di-tert-butylhydroquinone; BSA, 
bovine serum albumin; SDS, sodium dodecyl sulfate; HPLC, high 
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the contractile mechanism (20, 21), release of Ca2+ from the 
sarcoplasmic reticulum (22, 23), and  in  the translocation of 
Ca2+ between intracellular pools (24). However, little is known 
of the  nature  and i entity of the G proteins  present  in vascular 
smooth muscle. Attempts to characterize  them using pertussis 
toxin (PT) have been complicated by the variable effects of 
the toxin in different species and/or vascular beds. For ex- 
ample, responses are markedly inhibited  in the dog mesenteric 
vessel (25) and  in cultured cells from the  rat  aorta (26-28), 
partially inhibited in cultured cells from the rabbit renal 
artery (29), and  are  not affected in pig coronary arteries (30) 
or in a vascular smooth muscle cell line (31). Because G 
proteins were not characterized in these studies it is not 
known whether the  apparent discrepancies of the effect of PT 
are the consequence of variability in the nature of the G 
protein subunits present  in vascular smooth muscle from the 
different vessels. 
In the present study we examined the importance of G 
proteins in  a-thrombin-stimulated Ca2+ mobilization in cul- 
tured aortic smooth muscle. We initially characterize the 
major PT-sensitive G proteins present in vascular smooth 
muscle. We then demonstrate that a slowly ribosylating G 
protein, which represents less than 9% of the  total pool of 
ribosylated G proteins, is involved in the mobilization of Ca2+ 
by a-thrombin. Importantly, this G protein component does 
not  appear to play a role in the generation of IP3, and this, 
together with its slow time course of ribosylation, leads us to 
suggest that  this G protein is directly involved in  Ca2+ release 
from the sarcoplasmic reticulum. Our evidence indicating the 
existence of a slowly ribosylating G protein helps to clarify 
the apparent controversy as to the role of PT-sensitive G 
proteins  through which some vasoconstrictors elevate Ca2' in 
vascular smooth muscle (26, 30-32). 
EXPERIMENTAL  PROCEDURES 
Materials-a-Thrombin (from rat plasma), phenylmethylsulfonyl 
fluoride, Ponceau S, and Hepes were obtained from Sigma. 2,5-Di- 
tert-butylhydroquinone (tBuBHQ) was obtained from Fluka (Buchs, 
Switzerland). Thapsigargin was obtained from  LC Services (Woburn, 
MA). Ionomycin was from Calbiochem, and lanthanum chloride was 
from BDH Chemicals Ltd., Melbourne, Australia. Teric G12A9 was 
obtained from  IC1 Biochemicals, Sydney, Australia. Coomassie Bril- 
liant Blue protein assay was purchased from Pierce Chemical Co. 
Dulbecco's modified Eagle's medium, M199, fetal calf serum, and 
bovine serum albumin (BSA)  were purchased from ICN; Dulbecco's 
phosphate-buffered saline, Monomed, and all other cell culture prod- 
ucts were from the Commonwealth Serum Laboratories, Melbourne, 
Australia. Fura-2/AM was purchased from Molecular Probes, Eugene, 
OR. 
PT was purchased either from Sigma or from the Institute of 
Bioorganic Chemistry of the Ukrainian Academy of Sciences or was 
kindly provided by Dr. Vitaly 0. Rybin (USSR Cardiology Center). 
All three PT preparations gave identical results. U-49 (anti-836) 
antipeptide  antiserum was a generous gift of Drs. Alfred G. Gilman 
and Susan Mumby; A-10 (anti-ao), A-54 (anti-ad, A-56 (antiaid, 
584 (anti-a,), and GC-2 (anti-&)  antipeptide  antisera were kind gifts 
of Dr. Janet Robishaw (University of Texas Health Science Centre). 
Smooth Muscle Cell Culture-Aortic smooth muscle cells from 
adult WKY rats were isolated by enzymatic digestion as described 
previously (33). Experiments were performed on multiply passaged 
smooth muscle  cells. The cells were seeded onto glass coverslips and 
grown in Dulbecco's modified Eagle's medium containing 10% fetal 
calf serum. Cells reached confluence after 2 days, and  then  the serum 
in the medium  was replaced with 0.46%  BSA to induce cell  quiescence. 
Cells  were  used  24-48 h later. Treatment with PT was performed by 
replacing the growth medium with Dulbecco's  modified Eagle's me- 
dium containing the BSA in the presence or absence of PT (1 pg/ml) 
and incubating cells for the times indicated. 
Determination of Inositol Phosphates-Cells were  seeded into 24- 
well plates (2.0 cm2/well) in MI99 plus 10% fetal calf serum. At 
confluence the medium  was replaced with 0.5 ml of M119 plus 4% 
Monomed and 5 pCi  of my~-[~H]inositol (Amersham Corp.). After 48 
h the cells were washed (four times) with Dulbecco's phosphate- 
buffered saline to remove unincorporated my~-[~H]inositol  and  in- 
cubated in 1 ml of  M199 plus 4% Monomed and 20 mM LiCl for 15 
min at  37  "C in  a 5% CO;! incubator. Experiments were conducted by 
adding microliter quantities of agonists to the cells for the times 
indicated. The reaction was terminated by rapid addition of 1 ml  of 
stop solution to each well (1% SDS in 30 mM EDTA). Inositol 
polyphosphates were separated using Dowex  AG 1-X8 ion exchange 
resin as described elsewhere (34). Chromatography conditions were 
validated by running 3H-labeled inositol monophosphate, bisphos- 
phate, and IP3 standards.  Fractions  (6 ml) collected were  mixed with 
Insta-gel(l4 ml) (Packard  Instrument Co., Downer's  Grove, IL) and 
counted in  a liquid scintillation spectrometer. 
Intracellular Ca2' Measurement-The cell monolayers on cover- 
slips were loaded with Fura-2 (35) by incubation in 1 ml of Dulbecco's 
modified Eagle's medium containing 2 @M Fura-P/AM for 30 min at 
37  "C. The Fura-2/AM was added as  a 2 4  aliquot of 0.1% solution 
in dimethyl sulfoxide during the final 30 min of PT pretreatment. 
There was no difference in the loading of Fura-2  in  PT-pretreated or 
control cells. At  the end of the loading period coverslips were  washed 
in physiological salt solution (3 X 2 ml) and kept in the dark at  room 
temperature  until use; the cells were  used within 1 h of loading. The 
composition of physiological salt solution used in  the experiments 
was (in mM): 150 NaCI, 5 KCl, 1.8 CaC12, 1 MgSO,, 10 Hepes, 10 
glucose, pH 7.4, at 37  "C. Immediately before the experiment cover- 
slips were rapidly rinsed in physiological salt solution to remove any 
residual possibly leaked dye and inserted into a standard cuvette 
containing physiological salt solution. The cuvette with its stirring 
device was placed into the thermostatically controlled chamber at 
37 'C in  a SPEX dual wavelength 1681  fluorolog spectrometer. Ex- 
citation wavelengths were 340 nm and 380 nm, and emitted light 
collected at 505 nm. Readings were collected using the dM3000 
software (Spex Industries, Inc., Edison, NJ). Slit widths were set at 
1.5 mm on both excitation monochromators and 2.5 mm on the 
emission side. A 450-watt xenon arc lamp was  used as the light source. 
Integration time was  0.1 s at each wavelength, and  the time increment 
was  0.3 s. Determination of cell autofluorescence was performed on 
each coverslip after the experiment by the addition of 2 mM MnC12 
and 2 WM ionomycin to quench intracellularly located dye, and  this 
level  was subtracted from each wavelength reading before Ca2' levels 
were calculated. Typically, autofluorescence readings under basal 
conditions represented approximately 30% of each fluorescence read- 
ing. All drugs were added by direct injection of either 10- or 2 0 4  
volumes of stock solutions into the cuvette. The fluorescence readings 
at 340 nm were  divided by those at  380  nm to give a  ratio that was 
then processed according to the equation (35) [Ca"], = Kd.((R - 
R,in)/(R, - R ) ) .  (Sm/Sb2). [Ca2+lC is the intracellular free calcium 
ion concentration, the Kd for Fura-2 was assumed to be  224 nM (351, 
Rmax and Rmin are the maximal and minimal fluorescence ratios of 
Fura-2 acid in solution containing saturating Ca2+ (1 mM), or ca2+- 
free and EGTA (1 mM) and were  31.2 and 0.66, respectively. Sn and 
Sb2 are the fluorescence values at 380  nm in the absence and in the 
presence of saturating [Ca2+Ii, respectively. S~/SI,Z = 11.66 in our 
system. 
Electrophoresis-SDS-polyacrylamide gel electrophoresis was run 
through 12% gels according to Laemmli (36). Gels  were stained with 
Coomassie Brilliant Blue, dried, and autoradiographed. For quanti- 
tative determinations, pieces of gels containing labeled bands were 
excised and added to water for measurement of Cherenkov radiation. 
Electrophoretic blotting onto nitrocellulose was carried out follow- 
ing the procedure of Towbin et al. (37) in  a Mini-Transblot apparatus 
(Bio-Rad) overnight a t  45-60 V (usually 150-250 mA). Transfers 
were run at 100 V for the first 2 h  (current limit, 0.48 A) in a cold 
room using a Bio-Ice cooling unit, and  then  the voltage  was set to 
50-60 V (current limit, 0.25 A) for overnight electrophoresis. Transfer 
buffer was fortified with 0.0025-0.005% SDS for increased transfer 
of samples. Various amounts of membrane protein were blotted to 
ensure a linear relationship between the amount of antigen and  the 
amount of bound radioactive antibody. Proteins on blots were visu- 
alized with Ponceau S before blocking blots in TBS (Tris-buffered 
saline, 10 mM Tris-HCI, pH 7.5, 250 mM NaCl) containing 1% BSA 
and 0.05% Tween 20 (TBS-Tween-BSA) for 1 h. The Western blots 
were incubated sequentially with antipeptide antisera against selected 
G  protein  subunits followed by lZ5I-labeled anti-rabbit IgG (sheep or 
goat). All antibodies in TBS-Tween-BSA plus 0.01% NaN3 were of 
appropriate dilution to saturate binding sites. Blots were washed 
between incubation with TBS-Tween and finally (before drying) with 
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TBS alone.  Dried  blots  were  autoradiographed  with an intensifying 
screen  using  Kodak  XAR  film. 
Membrane  Preparations-The  aortic  smooth  muscle  cell  cultures 
were  washed three times  with  ice-cold  Dulbecco's  phosphate-buffered 
saline (Ca2+ and Mg2+ free), and cells  were  scraped  from  dishes into 
Dulbecco's phosphate-buffered  saline  using a rubber  policeman.  After 
centrifuging cells at - 3,000 X g for 10 min,  pellets were  homogenized 
in a motor-driven  glass-Teflon  homogenizer  in the medium consisting 
of 25 mM Na-Hepes (pH 7.5), 1 mM EDTA, and 100 p~ phenylmeth- 
ylsulfonyl fluoride. Homogenates were centrifuged in  an  Eppendorf 
microcentrifuge (13,000 rpm) for 30 min,  resuspended, and washed 
again  in the same manner. Resulting pellets were reconstituted in a 
small  volume of homogenization  buffer but with 10 p~ phenylmeth- 
ylsulfonyl fluoride. After resuspension, membranes were aliquoted 
and frozen in  liquid  nitrogen.  These preparations were  designated as 
"crude  smooth  muscle  cell  membranes" and used in  subsequent ADP- 
ribosylation and immunoblotting  experiments. 
Membranes were resuspended at protein concentrations within the 
range 0.5-2.5 mg/ml. Protein concentration was determined using 
the Coomassie Brilliant Blue protein  assay  with  BSA as a standard. 
ADP-ribosylation-Membranes from control and PT-treated 
smooth muscle  cells  were ADP-ribosylated  in  uitro  to  estimate  resid- 
ual PT substrate(s) using [32P]NAD. ADP-ribosylation was per- 
formed as described  previously (38) with  minor  modifications.  Briefly, 
membranes (5-15 pg of protein) were incubated at 37 "C for 60-90 
min in 40 p1 of medium containing 50 mM Tris-HC1,  pH 8.0, 1 mM 
EDTA, 2 mM MgC12, 10 mM dithiothreithol, 10 mM thymidine, 1 mM 
ATP, 0.1 mM GTP, 0.1 mM NADP, 0.1%  Lubrol PX, 10 p~ [aden- 
yk~te-~~PlNAD (specific  activity 4.7 Ci/mmol),  and 1 pg/ml PT. For 
these  studies, PT was activated by preincubation  with 5 mM ATP 
and 50 mM dithiothreitol for 15 min at 37  "C.  Under these  conditions 
all  available PT substrates became  labeled, and no significant deg- 
radation of NAD was observed. The reaction was terminated by 
adding concentrated (4 X)  SDS-polyacrylamide gel electrophoresis 
sample  buffer  and  immediate  boiling. 
Lubrol PX was usually added to membranes because it causes 
considerable  enhancement of PT-dependent ADP-ribosylation  (more 
than 2.5-fold in these  membranes).  In some cases,  Teric G12A9 was 
used instead of  Lubrol in the same concentration and with the same 
results. To ensure that differences  in  labeling of PT substrates were 
not a result of alterations in their physical availability for toxin, 
ADP-ribosylation rate, or NAD degradation, we carried out time 
courses of ADP-ribosylation of smooth muscle cell membranes in 
uitro. Labeling  reached its maximal  values  within  15 min and did not 
change  up to 1.5 h (data not  shown).  ADP-ribosylation  reactions were 
tested for  NAD survival  during the incubation time utilizing  TLC on 
cellulose plates in 50% ethanol, 0.3 M ammonium acetate, pH 5 .  Not 
less than 90% NAD  survived  in this medium  with  smooth  muscle  cell 
membranes up to 1.5 h  (not shown). 
Statistical  Analysis-Statistical  analysis  in  Fig. 9 was performed 
using  two-way analysis of variance,  and  results were  compared  using 
the standard  error of the difference. The averaging of multiple [Ca2+Ii 
traces was  performed  using a standard spreadsheet which calculated, 
at each time increment, the arithmetic mean of individual  Ca2+ values 
taken from multiple experiments. Thus, all Ca'+ traces  depicted  in 
the figures represent the mean of at least five similar  traces from 
separate  experiments. 
RESULTS 
Characterization of G Protein  Subunits 
Because G protein subunits have not been characterized 
previously in  vascular  smooth muscle we initially  examined 
the nature of the PT-sensitive G proteins present in the 
plasma  membranes of these cells. Membranes were prepared 
from  primary  cultured cells, exponentially growing cells, and 
confluent subcultured cells and G proteins assessed using 
immunoblotting  with specific antisera (Fig. 1). 
The  a-subunits,  Gan  and Gai:, are PT sensitive because of 
the  presence of a consensus sequence containing a cysteine 
residue (39), the acceptor site for ADP-ribosylation (40). 
These G q  subunits were found  to be present  in  all  three cell 
preparations in approximately equal amounts as judged by 
their intensity on autoradiographic film. Vascular smooth 
muscle  cells  were also  found  to possess the  Gas  protein which 
as 
p36 - ai2 - - ai3 - p35 
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FIG. 1. Characterization by immunoblotting of G protein 
subunits present in vascular smooth  muscle cells in culture. 
Membranes prepared from primary (lanes 1 and 4 ) ,  exponentially 
growing (lanes 2 and 5), or confluent  subcultured  (lanes 3 and 6) cells 
were  probed  with antisera raised against GcY,, G w ,  GCY,~, GPY,, G& 
protein  subunits. 10 pg of protein was loaded  in  each  case.  Lanes 1-3 
were  probed sequentially with antibodies to CY,, cq2, and 836. Lanes 4- 
6 were probed with antibodies to aj3 and &. All lanes were then 
probed with a '2sI-labeled anti-rabbit IgG. 
is known to couple to  adenylate cyclase (18). Interestingly, 
primary  cultured  smooth muscle cells contained significantly 
less Gas  than  the  exponentially growing and  confluent  syn- 
thetic cultures. No detectable levels of the PT-sensitive a- 
subunit found most abundantly in neural tissue, a", were 
found  in  smooth muscle cell membranes because no  immu- 
noreactivity was  observed on  blots  probed  with  the  anti-a,)- 
specific antisera A-10 (not shown). 
Two  P-subunits of G proteins, GB,, and which are 
approximately 10% different  in  amino acid  sequence (41, 42) 
and coded for  by  different genes (42), could also be detected 
with  antisera raised against specific peptides. Both  &subunits 
were present in approximately equal amounts in all three 
preparations. A lower molecular  weight  species  was also ob- 
served on  blots  probed  with  antisera  against  the ai,- and &- 
subunits.  The  nature of this  protein  is  unknown a t  present; 
however, it  showed differential expression in that it was 
detected in primary and confluent cultures but not in the 
exponentially growing cells. 
These results indicate that vascular smooth muscle cells 
possess multiple G proteins which may serve a variety of 
functions. 
Assessment of Intracellular Ca2+ Mobilization by a-Thrombin 
Estimation of intracellular Ca'+ mobilization is normally 
carried  out  by  measuring  Ca2+  elevations  in nominally Ca"- 
free  media or  in media containing  EGTA  in excess of Ca2+.  A 
possible drawback to  these  strategies  is  that removing extra- 
cellular  Ca2+ has  the  potential  to lower Ca'+ in  the  internal 
stores. T o  investigate  whether  this was a problem in vascular 
smooth muscle, we compared  Ca2+ elevations  with a-thrombin 
in  the  presence of external Ca2+, in  the presence of lanthanum 
ions  to block Ca2+ entry,  and  in  the presence of EGTA  to 
chelate  extracellular Ca2+. 
The  rise  in Ca2+ induced by a-thrombin was found  to be 
comprised of an initial  transient  peak, caused by Ca2+ release 
from internal stores, and a sustained phase, presumably 
caused by Ca2+  entry. Fig. 2 shows that  the response in  the 
presence of lanthanum (200 PM) precisely matches  the  initial 
transient peak observed in the control response with no 
evidence of a sustained phase. In  contrast,  treatment with 
EGTA (1 mM) produced first a slow decline in base line 
followed by a  markedly attenuated  Ca2+ release. This effect 
of EGTA is consistent  with  it  causing a slow "leeching out" 
of Ca2+ from agonist-sensitive internal pools. Therefore, it 
was decided to employ Caz+  channel blockade  with lanthanum 
as a means  to  quantitate  internal  Ca2+ release. 
PT and a-Thrombin-induced Ca2+ Mobilization 
Short-term PT Treatment-PT was used to  examine  the 
contribution of G proteins  in  the  intracellular Ca'+ response 
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FIG. 2. Effect of lanthanum and EGTA on the @-thrombin 
(THR)-induced rise in cytoplasmic free Ca2+ concentration in 
vascular smooth muscle cells. The cytoplasmic Ca2+  concentration 
in monolayers of smooth muscle cells was monitored using fura-2 and 
dual-wavelength fluorescence spectroscopy as described under “Ex- 
perimental Procedures.” For the lanthanum treatment, LaCl (200 
g ~ )  was added a t  60 s. For the EGTA treatment coverslips were 
transferred  into buffer containing  EGTA (1 mM) and no added Ca2+ 
approximately 30 s prior to  the  start of the experiment.  Each trace is 
the mean of three similar  experiments. 
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FIG. 3. Time course of PT-induced 
6 7 8  
ADP-ribosvlation in 
vascular smooth muscle  cells. SDS-polyacrylamide gelelectropho- 
resis autoradiogram showing the reduction in  the ability of PT to 
ADP-ribosylate  G  proteins in membranes  prepared from intact cells 
pretreated for increasing periods of time  with PT (1 pglml).  ADP- 
ribosylation was determined using PT-catalyzed incorporation of 
[“PINAD as described under “Experimental Procedures.” Lanes 1 
and 2,3 and 4, 5 and 6, and 7 and 8 were pretreated with PT for 0, 
1, 2, and 4 h, respectively. Lanes I, 3 , 5 ,  and 7 represent  membranes 
incubated in uitro with [32P]NAD in  the absence of PT,  and lanes 2, 
4, 6, and 8 are membranes  incubated in  uitro with [32P]NAD in the 
presence of PT. Molecular weight standards  are shown on  the left. 
to a-thrombin. First,  the time course of PT-mediated ADP- 
ribosylation of the G proteins in smooth muscle cells was 
assessed by incubating intact cells for various periods of time 
with PT (1 pg/ml), preparing membranes from these cells, 
and  testing  the subsequent ability of PT to incorporate 32P- 
labeled NAD. PT produced a  rapid effect in intact cells; the 
proportion of PT-sensitive G protein  left unribosylated after 
1, 2, and 4 h of pretreatment was 21.6,  8.7, and 2.6%  of that 
present in untreated cells, respectively (Fig. 3). No ADP- 
ribosylation of species with molecular mass lower than 36 
kDa was observed (not shown). 
Because the  amount of PT-induced ADP-ribosylation was 
greater than 90% a t  2 h, we tested the effect of this period of 
PT pretreatment on  a-thrombin-induced Ca2+ mobilization. 
Treatment of cells for 2 h with PT did not affect the Ca2+ 
response to a maximal concentration of a-thrombin (2 units/ 
ml) (Fig. 4). This raised the possibility that the residual 
component (approximately 8.7% of total) of PT-sensitive G 
protein was sufficient to couple a-thrombin receptors to Ca2+ 
release. 
Long Term PT Treatment-To obtain ADP-ribosylation of 
the  total amount of PT-sensitive G proteins  present  in  vas- 
cular smooth muscle, long term (18 h)  treatment was  used. 
Fig. 5A shows that treatment of cells with PT for 18 h 
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FIG. 4. Effect of short  term  PT  treatment on a-thrombin 
(THR)-induced Ca2+ mobilization in  vascular smooth  muscle 
cells. The effect of a-thrombin (2  units/ml)  on the release of intra- 
cellular Caz+ was tested on cell monolayers pretreated for 2 h in  the 
presence or absence of P T  (1 pg/ml). The ability of a-thrombin  to 
release Ca2+ from intracellular  stores was determined by using lan- 
thanum ions (200 g ~ ) .  a-Thrombin  and  lanthanum were added a t  
the times indicated. P T  pretreatment (2 h) was performed as de- 
scribed under  “Experimental Procedures.“ 
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FIG. 5. Residual nonribosylated PT-sensitive G proteins in 
membranes of vascular smooth  muscle cells preexposed to PT 
for 18 h. A, cells were incubated in culture for 18 h in  the absence 
(lanes 1 and 2) or presence (lanes 3 and 4 )  of P T  (1 pglrnl), and 
membranes were prepared as described under  “Experimental Proce- 
dures.’’ Membranes were incubated with [32P]NAD in the absence 
(lanes 1 and 3 )  and presence (lanes 2 and 4 )  of PT in  the ribosylation 
mixture. 5.9 gg of membrane  protein was used in all lunes. B, the 
time course of ADP-ribosylation as assessed by counting the [”PI 
NAD radioactivity present in excised bands. Ribosylation is expressed 
as a percentage of control cells not exposed to PT. The curue shown 
is typical of three separate experiments. 
inactivated all PT-sensitive G proteins, within the limits of 
detection. In addition, measurement of radioactivity present 
in excised bands revealed no incorporation of [32P]NAD in 
membranes pretreated for 18 h (Fig. 5B). The effect of long 
term pretreatment with PT on Ca2+ release is  shown in Fig. 
6. Long term treatment was found to reduce markedly a- 
thrombin-induced Ca2+ release, indicating that  the residual 
8.7% of PT-sensitive G proteins left after  a 2-h PT pretreat- 
ment accounts for most of the Ca2+ response. In addition, 
despite the fact that long term PT treatment inactivated all 
PT-sensitive G proteins  present, 28% of the Ca2+ response to 
a-thrombin remained, indicating that PT-insensitive G pro- 
teins or G protein-independent mechanisms may  be  involved 
in mediating this residual component of Ca2+ release from 
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FIG. 6. Effect of long term PT treatment on a-thrombin 
(THR)-induced Caz+ mobilization in vascular smooth muscle 
cells. The effect of a-thrombin (2 units/ml)  on the release of intra- 
cellular Ca2+ was tested on cell monolayers pretreated for 18 h  in the 
presence or absence of PT (1 pglml). a-Thrombin  and lanthanum 
were added at  the times indicated. PT pretreatment was performed 
as described under "Experimental Procedures." 
I 
C PT 
FIG. 7. GBsa- and Gats-subunits present in membranes of 
vascular smooth muscle cells before and 18 h after exposure 
to PT. Autoradiogram of an immunoblot using specific antisera 
raised against a i 3  and @35 G protein subunits. The [eft lane represents 
membranes prepared from control (C) cells; the right lane was from 
cells treated with PT (1 pg/ml) for 18 h. Exactly 15 pg  of protein was 
loaded in each case. 
internal stores. It is also interesting to note here that no 
marked effects were observed on Ca2+ entry,  as assessed by 
comparing the sustained  phases of the Ca2+ elevations in the 
absence of lanthanum  (data  not shown). 
PT and  Go-subunits 
It was shown recently that long term PT treatment of cells 
can produce down-regulation of the levels of the @ subunit of 
G proteins, thereby causing nonspecific inhibition of all G 
proteins  present (43). We tested  this by measuring levels of 
GBss and ai, in membranes  prepared from control and long 
term PT-treated cells, using immunoblotting with specific 
antisera. No marked alteration in the level of either  the p35- 
or  the  q3-subunit was detected (Fig. 7). Thus,  the reduction 
in  a-thrombin-mediated Ca2+ release by long term PT pre- 
treatment in  these cells was caused by a specific inhibition of 
PT-sensitive  G  protein subunits  rather  than a reduction in 8- 
subunit levels. 
PT and Ca2+ Stores 
Recent reports have implicated the involvement of GTP- 
binding proteins  in communication between distinct intracel- 
lular Ca2+ pools (24). To test the possibility that PT was 
affecting the size of the agonist-sensitive Ca2+ pool, the effects 
of PT were tested  on  Ca2+ release induced by two agents that 
act independently of IP, generation. tBuBHQ, which has been 
shown to release Ca2+ selectively from the IP,-sensitive Ca2+ 
pool (44), caused a  rapid increase in  [Ca2+Ii  in the presence of 
La3+, which was not affected to  any great extent by short term 
exposure to PT (Fig. 8A) .  Similarly, thapsigargin, an inhibitor 
of Ca2+ uptake into  internal stores (45), produced a slower 
increase in Ca2+ levels but was also unaffected by PT treat- 
ment (Fig. 8B).  Intracellular  Ca2+ release induced by either 
agent was also not affected by long term (18 h) PT treatment 
(data  not shown). These  results provide evidence to suggest 
that PT was not affecting the size of the agonist-sensitive 
Ca2+ pool in vascular smooth muscle. 
PT and  a-Thrombin-induced  PHJIP:,  Formation 
It was possible that  the marked  inhibition of Ca2+ release 
in long term  PT-treated  but  not  short  term  PT-treated cells 
was caused by a  greater effect of PT on IP, formation at 18 
h. However, no correlation between the inhibition of IP, 
formation and  the inhibition of Ca2+ release was observed. 
Fig. 9 shows that  treatment of cells for 2  h  with PT (which 
produces 91.3% ADP-ribosylation of PT-sensitive  G  proteins) 
significantly attenuated ( p  < 0.05) a-thrombin-induced IP3 
formation both in  the presence or absence (not shown) of 
LaR+ (200 PM). However, although an 18-h PT pretreatment 
produced total ADP-ribosylation, no further inhibition of IP3 
formation was seen (i.e. the  extent of inhibition after 18 h 
was not significantly greater than  after a 2-h pretreatment; p 
> 0.10) despite there being a  marked effect on  Ca2+ release. 
Similar  results were obtained when we measured the products 
of phosphoinositide hydrolysis using HPLC. For these exper- 
iments we measured inositol 4-monophosphate and inositol 
1,3,4-trisphosphate, two products that accumulate in the pres- 
ence of lithium and which are good indicators of flux through 
the phosphorylation and dephosphorylation pathways of IPS 
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FIG. 8. Effect of PT on Ca2+ release induced by tBuBHQ (20 
PM) ( A )  and thapsigargin (2 p ~ )  ( B )  in vascular smooth  muscle 
cells. Cells  were incubated with or without PT (1 pg/ml) for 2 h, and 
Fura-2/AM was added for the final 30 min. All traces are means of 
data from two similar experiments. La2+ and the Ca2+ mobilizing 
agents were added as indicated. 
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FIG. 9. Effect of PT on  a-thrombin-induced IP, formation 
in  vascular  smooth muscle cells. Cells were exposed to PT (1 pg/ 
ml) for 0, 2, or 18 h before measurement of [3H]IP3 formation 
stimulated by a-thrombin over 30-9 (striped histograms) or 5-min 
(dotted histograms) periods. Results shown are the mean of three 
separate experiments conducted in triplicate. Error bars represent 
S.E. Asterisks indicate statistically significant differences from cells 
not treated with PT ( p  < 0.05). 
metabolism. We found very little difference between the level 
of inhibition of either inositol 4-monophosphate or inositol 
1,3,4-trisphosphate accumulation by 2- or  18-h PT treatment 
of cells. The accumulation of inositol 4-monophosphate in 
response to thrombin (which increased 4.8-fold over basal) 
was inhibited by 66.6 and 71.5%, and the accumulation of 
inositol 1,3,4-trisphosphate (17.7-fold increase over basal) was 
inhibited by 87.4 and 88.4% by 2- and 18-h PT treatment, 
respectively. These results indicate that first, a-thrombin 
receptor coupling to phospholipase C appears to occur via 
PT-sensitive and PT-insensitive mechanisms; and second, 
inhibition of Ca2+ release after  18-h  but  not  after 2-h pretreat- 
ment is not caused by increased inhibition of phospholipase 
C, and therefore the residual 8.7% of PT-sensitive  G  proteins 
does not  appear to be  involved in coupling to  this enzyme. 
DISCUSSION 
Our observations on the effects of PT on a-thrombin- 
induced Ca2+ mobilization in  intact cells suggest that a slowly 
ribosylating G protein is directly involved in IP3-mediated 
Ca'+ release from intracellular pools. Evidence supporting 
this conclusion is based on the findings that: (a) a small 
component representing less than  9% of the  total  PT-sensi- 
tive G  proteins is ADP-ribosylated only after long term  ex- 
posure to PT; ( b )  whereas a-thrombin-stimulated IP3 forma- 
tion is maximally inhibited after a 2-h exposure to  PT, a- 
thrombin-induced Ca2+ release is reduced only after long term 
PT exposure; and (c) PT has no effect on Ca2+ release induced 
by agents acting independently of IP3. In these studies we 
also demonstrate that multiple G proteins are present in 
vascular smooth muscle and  that coupling to either phospho- 
lipase C or Ca2+ release occurs via both PT-sensitive and 
-insensitive mechanisms. 
A possible explanation for our  results  is that  there may  be 
marked differences in the kinetics of ADP-ribosylation of the 
individual Gai-subunits so that one of either Gai2 or Gai3 is 
significantly ADP-ribosylated only after long term PT treat- 
ment  and is therefore able to elicit full Ca2+ responses in short 
term  PT-treated cells. In separate experiments we set out to 
determine which a-subunits were ADP-ribosylated and  the 
extent  to which each was ribosylated after PT treatment of 
cells for 2 h. We found that it was possible to observe a 
doublet in the 41-kDa region, which corresponds to separation 
of Gai2 and Gaia, if membrane protein was run on large 
electrophoresis gels. Both  bands of this doublet were  signifi- 
cantly ADP-ribosylated by 2 h of PT treatment of intact cells 
(data  not shown). In addition, two-dimensional electropho- 
resis experiments, which resulted in better separation of Gai2- 
and  Gai3-subunits, produced identical results. Thus, although 
we have not performed a detailed time course experiment we 
can report that there  appears to be no major difference in the 
extent of ADP-ribosylation of Gaiz  and  Gai3 after  a 2-h PT 
treatment of cells, and therefore it does not provide an expla- 
nation for the marked differences observed on Ca2+ mobili- 
zation between the two periods of PT treatment. 
Previous work has been inconclusive as to whether PT- 
sensitive G proteins are involved in agonist-dependent re- 
sponses in vascular smooth muscle. For instance, endothelin- 
stimulated inositol polyphosphate production is partially in- 
hibited in cells cultured from the rabbit renal artery (29) 
whereas endothelin-stimulated IP3 production in the A-10 
vascular smooth muscle  cell line is not affected (31). In  rat 
aortic smooth muscle cells, agonist-induced Ca2+ elevations 
have  been shown to be sensitive to PT although by different 
degrees (26-28). a-Thrombin-induced  alterations in pH, have 
also been shown to be inhibited by PT in these cells (7). In 
studies on whole  vessels, contractions  are inhibited by PT in 
dog mesenteric artery (25) but  not in the pig coronary artery 
(30). Electrophysiological studies of Ca2+  channels in guinea 
pig mesenteric artery have also shown a lack of effect of PT 
even though the channels appear to be dependent on a G 
protein (32). The differences in the sensitivity to PT could be 
explained by the different treatment periods used in each 
study. For instance, noradrenaline-stimulated increases in 
quin-2 fluorescence in rat aortic smooth muscle cells were 
sensitive to PT only if cells were  exposed for periods in excess 
of 9  h (26). In  the present study we show that although short 
term exposure to PT produces a maximal effect on IPS for- 
mation, inhibition of Ca2+ release is seen only after long term 
exposure, indicting that these two systems may  involve dif- 
ferent  G  proteins that follow different time courses of PT- 
catalyzed ADP-ribosylation. 
Several factors led us to suggest that  this G protein exerts 
its action at the level of the sarcoplasmic reticulum. The 
pathway requires long term exposure (>2 h)  to PT before it 
is inactivated by ADP-ribosylation, which suggests that PT 
is not ribosylating a  G protein on the plasma membrane but 
rather is being internalized and is ribosylating a cytosolic or 
microsomal protein. The time course of inactivation of Ca2+ 
release is consistent with the time taken for internalization 
of extracellular molecules by endocytotic mechanisms in 
smooth muscle (46). Another finding that is consistent with 
the G  protein  not  acting at  the plasma membrane is that  the 
pathway does not appear to be involved in the mechanisms 
which generate IPS, i.e. phospholipase C activation. IPS for- 
mation is maximally inhibited after a 2-h exposure to  PT, 
whereas Ca2+ release is not affected after that  short period of 
exposure. Thus, although the possibility that  the G protein is 
plasma membrane bound cannot be excluded, the present 
findings suggest that PT is inactivating a component located 
deeper within the cell. Several reports have demonstrated 
GTP-binding  proteins  present within the cytosol (47). The 
major cytosolic G  protein present in bovine smooth muscle is 
rhoA  p21, a member of the ras p21-like superfamily of GTP- 
binding proteins (48). A G protein has also been postulated 
to modulate the sensitivity of the contractile mechanism in 
smooth muscle (20, 21). These proteins appear to be distinct 
from those that couple receptors to various effectors on the 
plasma membrane (47-49), and it is likely that they have 
important intracellular functions. In addition to these, the 
Ga-subunits of the more classical G proteins have  been de- 
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tected  in the cytosol and  appear to be present  as uncomplexed 
species (50). For  instance, the PT-sensitive ai has been de- 
tected in a hepatic microsomal fraction (51). Thus,  it is not 
unreasonable to suggest that  in vascular smooth muscle, one 
or more of these cytosolic proteins  are involved in  Ca2+ release. 
There is also increasing evidence to suggest that GTP- 
binding proteins  are involved in modulating Ca2+ release from 
intracellular stores (52). This concept originated from the 
findings that  in permeabilized cells or  in isolated subcellular 
fractions, GTP is  a  potent releasing agent on its own and also 
greatly enhances Ca2+ release induced by IP, (53-56). The 
mechanism of GTP-stimulated Ca2+ release is still unresolved; 
however, it has been suggested recently that small GTP- 
binding proteins may enhance  Ca2+ release by fusing small 
microsomal vesicles together (52) or by promoting the  trans- 
location of Ca2+ from an IP,-insensitive to  an IP3-sensitive 
calcium pool (24). In vascular smooth muscle, recent evidence 
has implicated a role for a GTP-binding protein in Ca2+ 
release (22). In saponin-permeabilized rabbit mesenteric ar- 
tery (23, 57) and primary cultured rat aortic smooth muscle 
cells (23) IP,-dependent Ca2+ release shows an absolute re- 
quirement for GTP.  The nonhydrolyzable analogue GppNHp, 
substitutes adequately for GTP, suggesting that  GTP binding 
rather  than hydrolysis is involved (57). Strong evidence that 
a G protein is involved in IP3-dependent Ca2+ release was 
obtained from the skinned  artery  preparation  in which IP,- 
but not caffeine-induced Ca2+ release was inhibited by PT 
(23). Therefore, taken together with our  present findings in 
intact cells it appears likely that a  PT-sensitive  G protein is 
directly involved in IP3-dependent Ca2+ release from the 
sarcoplasmic reticulum. 
It is possible that  the G  protein is directly coupled to  the 
Ca2+ channel on the sarcoplasmic reticulum. A wide variety 
of membrane ion channels  are directly modulated by G  pro- 
teins (58). Sequence and  structural analysis has shown that 
the sarcoplasmic reticulum Ca2+ channel activated by IP3 
comprises part of the IP, receptor protein (59). The IP3 
receptor includes a large cytoplasmic N terminus domain 
which contains the IP3 recognition site (59) and putative 
regulatory domains (60). This region of the receptor contains 
sites for phosphorylation by CAMP-dependent protein kinase 
(61), protein kinase C, and Ca2+/calmodulin-dependent pro- 
tein kinase I1 (62). It is suggested in  the present study that 
the  IPS receptor also contains  a recognition site for a regula- 
tory  G  protein. An attractive hypothesis is that a  G  protein 
may be directly involved in modulating the affinity state of 
the  IP3 receptor (or perhaps the affinity state for intraluminal 
Ca2+), which has been proposed to control Ca2+ flux (63). The 
residual Ca2+ release component after long term PT treatment 
may represent  IP3-mediated  Ca2+ release in the absence of a 
coupled G  protein, and  this G  protein-independent basal Ca2+ 
flux may account for the IP,-mediated Ca2+ release from 
purified IP, receptors inserted  in lipid bilayers (64,65) which 
lack a coupled G protein. 
Alternatively, it  is possible that PT is affecting communi- 
cation between intracellular  Ca2+ pools. I t  has been suggested 
recently that translocation of Ca2+ between IP,-sensitive and 
IP3-insensitive Ca2+ pools in DDTIMF-Z smooth muscle cells 
is activated by a class of small GTP-binding  proteins (24,56). 
Although these proteins appear to be distinct from the G 
proteins that  interact with receptors on the plasma membrane 
(47-49), they may contain consensus sites for ADP-ribosyla- 
tion by PT (40). We could not provide evidence to support 
this hypothesis; Ca2+ elevations in response to tBuBHQ, a 
releaser of Ca2+ from IP3-sensitive pools (44), or thapsigargin, 
an endoplasmic reticulum Ca2+ ATPase  inhibitor (45), were 
not  altered by PT treatment.  This does not necessarily rule 
out  a role for a  PT-sensitive pathway mediating communica- 
tion between pools if communication is controlled by an 
inositol phosphate because these compounds act independ- 
ently of inositol polyphosphates. However, these results do 
provide an important control in that PT does not appear to 
affect the total  amount of releasable Ca2+. Another possibility 
worth noting here is that PT may  be affecting the interaction 
of the IP3-sensitive Ca2+ pool with the plasma membrane. It 
was suggested recently that in rat liver the IP3-sensitive 
organelle is anchored to  the plasma membrane through actin 
microfilaments (66). If a G protein is also involved, then 
inactivation by  long term PT treatment may cause a  redistri- 
bution of these pools in the cell such that, because of its rapid 
metabolism, less of the IP, generated at  the plasma membrane 
would reach its receptor, which  would result in a reduced Ca2+ 
response. A close association of IP3-sensitive Ca2+ pools to 
the plasma membrane is supported by our finding that PT 
inhibited greater than 50% of IP, formation without affecting 
Ca2+ mobilization in response to thrombin. This may indicate 
that there is considerable “spare” IPS in stimulated vascular 
smooth muscle cells and  that  the amount remaining after PT 
treatment is adequate to mobilize Ca2+ fully. This is not 
unexpected if the Ca2+ pools that  are most sensitive to  IP3 lie 
directly beneath the plasma membrane close to  the sites of 
IP, formation. IP, in these regions  could well  be produced in 
excess of that which is required for activation of Ca2+ release. 
The concept of spare G protein was  used several years ago to 
explain why in hepatocytes, angiotensin 11-induced inhibition 
of adenylate cyclase  was not lost until greater than 90% of 
the G  protein was ADP-ribosylated by PT (67). By analogy, 
it could be argued that  the reason for why Ca2+ release is not 
inhibited until greater than 91.3% of the G protein is ADP- 
ribosylated is  the presence of spare IP,. This could not be the 
case because the levels of IP3 present in cells that contained 
91.3 or 100% ADP-ribosylation were identical. Thus, we can 
only conclude that  the residual G protein left unribosylated 
after  a 2-h treatment  is  not involved in coupling to phospho- 
lipase C, and  it is suggested that  this represents  a  separate 
pool of G  protein which regulates internal  Ca2+ release. 
We have also demonstrated that vascular smooth muscle 
cells contain  G  proteins of the G, and Gi subfamilies; however 
the presence of additional  a-subunits  appears likely. The PT- 
sensitive G  proteins probably belong to  the  Gai subfamilies 
which contain consensus sequences for PT-catalyzed ADP- 
ribosylation (40), and recent evidence has indicated that 
several of these proteins can be activated by a single receptor 
(68). These  G  proteins have also been demonstrated to acti- 
vate phospholipase C  in  other cells (69), and therefore it is 
likely that  the PT-sensitive  Gai2  and  Gaia  subunits  are  in- 
volved in coupling a-thrombin  to phospholipase C activation 
in vascular smooth muscle.  Our  evidence also indicates that 
PT-insensitive G proteins interact with phospholipase C. 
Several PT-insensitive  G  proteins have also been identified 
in other cells, including Gza (39), and more recently, Gq, 
which has been shown to activate phospholipase C (70). 
Determination of which of these proteins  are activating phos- 
pholipase C in vascular smooth muscle cells requires investi- 
gation; however, it is clear from our data that these cells 
contain multiple G  proteins which are able to couple thrombin 
receptor activation to Ca2+ mobilization. 
It is becoming evident that  the coupling of receptors to 
various effector systems, or even to  the one effector, involves 
multiple G  proteins (68,71). Thus, in vascular smooth muscle, 
a-thrombin activates different G  proteins which could sub- 
serve different cellular functions ranging from contraction (5) 
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to gene  transcription (8) and  mitogenesis (6). In the present 
study  evidence has been  provided  indicating  a  new  component 
in the signaling  pathway  which  couples a-thrombin receptor 
activation to Ca2+  release. This pathway  involves  a PT-sen- 
sitive G protein that appears to be involved  directly  in IP3- 
dependent  Ca2+  release. The G protein  could  therefore  play  a 
major role in mediating the propagative Ca2+ release which 
occurs  after  exposure of cells to a-thrombin (9). 
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